| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1006432707 |
| P356 | DOI | 10.1186/S12979-016-0080-1 |
| P8608 | Fatcat ID | release_gvrqpibyvfdqvgbd2bxz4dt5wq |
| P3181 | OpenCitations bibliographic resource ID | 3914953 |
| P932 | PMC publication ID | 4995820 |
| P698 | PubMed publication ID | 27559355 |
| P50 | author | Mariateresa Ambrosio | Q58968177 |
| Francesca Biagioni | Q42143931 | ||
| Albino Carrizzo | Q42234021 | ||
| Carmine Vecchione | Q42234034 | ||
| Antonio Damato | Q42710829 | ||
| Carla L Busceti | Q56904752 | ||
| Francesco Fornai | Q56904796 | ||
| Maurizio Forte | Q57053641 | ||
| P2093 | author name string | Annibale A Puca | |
| Michela Ferrucci | |||
| P2860 | cites work | A new role for Nogo as a regulator of vascular remodeling | Q24318615 |
| Long pentraxin 3/tumor necrosis factor-stimulated gene-6 interaction: a biological rheostat for fibroblast growth factor 2-mediated angiogenesis | Q28118263 | ||
| Structure and function of the pentraxins | Q28302580 | ||
| Endothelial nitric oxide synthase in vascular disease: from marvel to menace | Q28305279 | ||
| Inflammation in atherosclerosis | Q29547428 | ||
| The pentraxins PTX3 and SAP in innate immunity, regulation of inflammation and tissue remodelling | Q33632041 | ||
| Inflammatory biomarkers in atherosclerosis: pentraxin 3 can become a novel marker of plaque vulnerability | Q33768947 | ||
| Pentraxin 3 (PTX3) is associated with cardiovascular risk factors: the Health 2000 Survey | Q57417409 | ||
| The Angiogenic Factor PlGF Mediates a Neuroimmune Interaction in the Spleen to Allow the Onset of Hypertension | Q61455305 | ||
| Prognostic value of pentraxin 3 in patients with chronic heart failure | Q80111779 | ||
| Pentraxin 3 is a new inflammatory marker correlated with left ventricular diastolic dysfunction and heart failure with normal ejection fraction | Q83395035 | ||
| Elevated pentraxin-3 levels are related to blood pressure levels in hypertensive patients: an observational study | Q83784757 | ||
| Elevated concentrations of pentraxin 3 are associated with coronary plaque vulnerability | Q84370651 | ||
| Serum and Vitreous Pentraxin 3 Concentrations in Patients with Diabetic Retinopathy | Q87210219 | ||
| Remote transplantation of mesenchymal stem cells protects the heart against ischemia-reperfusion injury | Q87375646 | ||
| Elevated Plasma Pentraxin3 Levels and Its Association with Neovascular Age-related Macular Degeneration | Q87488813 | ||
| PTX3, A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans | Q33912738 | ||
| Production of the long pentraxin PTX3 in advanced atherosclerotic plaques | Q34128059 | ||
| Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study | Q34150807 | ||
| Pentraxin 3, a non-redundant soluble pattern recognition receptor involved in innate immunity | Q34199395 | ||
| PTX3 plays a key role in the organization of the cumulus oophorus extracellular matrix and in in vivo fertilization | Q34302929 | ||
| Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction | Q34357988 | ||
| Cloning of mouse ptx3, a new member of the pentraxin gene family expressed at extrahepatic sites | Q34380249 | ||
| Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility | Q34403569 | ||
| Human pentraxin 3 (PTX3) as a novel biomarker for the diagnosis of pulmonary arterial hypertension | Q34430183 | ||
| Pentraxin3 in chronic thromboembolic pulmonary hypertension: a new biomarker for screening from remitted pulmonary thromboembolism. | Q34549800 | ||
| Elevated plasma pentraxin 3 and its association with retinal vein occlusion | Q34551919 | ||
| Pentraxins in innate immunity: from C-reactive protein to the long pentraxin PTX3. | Q34683473 | ||
| Prognostic value of plasma pentraxin-3 levels in patients with stable coronary artery disease after drug-eluting stent implantation | Q34694726 | ||
| Elevated circulating levels and tissue expression of pentraxin 3 in uremia: a reflection of endothelial dysfunction. | Q34713240 | ||
| Pentraxin 3 mediates neurogenesis and angiogenesis after cerebral ischaemia. | Q35021428 | ||
| Systemic and Ocular Long Pentraxin 3 in Patients with Age-Related Macular Degeneration | Q35692264 | ||
| Pentraxin 3: a novel biomarker for inflammatory cardiovascular disease | Q35755280 | ||
| Inflammation as a cardiovascular risk factor | Q35789860 | ||
| Coronary artery disease in the developing world | Q35816354 | ||
| Pattern recognition by pentraxins | Q36008865 | ||
| Pentraxin-3 Predicts Long-Term Cardiac Events in Patients with Chronic Heart Failure | Q36249503 | ||
| Integrase-deficient lentiviral vectors mediate efficient gene transfer to human vascular smooth muscle cells with minimal genotoxic risk | Q36469473 | ||
| Human retinal pigment epithelial cells express the long pentraxin PTX3 | Q36594348 | ||
| Vascular pentraxin 3 controls arterial thrombosis by targeting collagen and fibrinogen induced platelets aggregation | Q36869842 | ||
| Associations of pentraxin 3 with cardiovascular disease and all-cause death: the Cardiovascular Health Study | Q37141153 | ||
| The long pentraxin PTX3 is crucial for tissue inflammation after intestinal ischemia and reperfusion in mice | Q37164532 | ||
| Pentraxins, anti-pentraxin antibodies, and atherosclerosis | Q37328097 | ||
| The acute-phase protein PTX3 is an essential mediator of glial scar formation and resolution of brain edema after ischemic injury | Q37627769 | ||
| The time profile of Pentraxin 3 in patients with acute ST-elevation myocardial infarction and stable angina pectoris undergoing percutaneous coronary intervention. | Q37668815 | ||
| Inflammation in atherosclerosis: transition from theory to practice | Q37672113 | ||
| The long pentraxin PTX3: a modulator of the immunoinflammatory response in atherosclerosis and cardiovascular diseases. | Q37775325 | ||
| Endothelial nitric oxide synthase, vascular integrity and human exceptional longevity | Q38059901 | ||
| Transcriptional regulation by infliximab therapy in Kawasaki disease patients with immunoglobulin resistance | Q38306167 | ||
| Brain diseases and tumorigenesis: The good and bad cops of pentraxin3. | Q38612312 | ||
| Upregulation of genes for C-reactive protein and related pentraxin/complement proteins in photodynamic therapy-treated human tumor cells: enrolment of PI3K/Akt and AP-1. | Q39238470 | ||
| Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists | Q40498531 | ||
| Pentraxin 3 Induces Vascular Endothelial Dysfunction Through a P-selectin/Matrix Metalloproteinase-1 Pathway | Q41276392 | ||
| Serum Pentraxin-3 Level in Patients Who Underwent Coronary Angiography and Relationship with Coronary Atherosclerosis | Q41741922 | ||
| Honokiol ameliorates endothelial dysfunction through suppression of PTX3 expression, a key mediator of IKK/IκB/NF-κB, in atherosclerotic cell model | Q42416522 | ||
| C-reactive protein and all-cause mortality--the Copenhagen City Heart Study | Q43083822 | ||
| Plasma Pentraxin 3, but not high-sensitivity C-reactive protein, is a useful inflammatory biomarker for predicting cognitive impairment in elderly hypertensive patients | Q43142703 | ||
| Clinical and prognostic implications of circulating pentraxin 3 levels in non ST-elevation acute coronary syndrome | Q43881033 | ||
| Pentraxin 3 inhibits fibroblast growth factor 2-dependent activation of smooth muscle cells in vitro and neointima formation in vivo | Q43905775 | ||
| The CVD paradox: mortality vs prevalence | Q44591764 | ||
| The role of pentraxin 3 as diagnostic value in classification of patients with heart failure | Q44694286 | ||
| Modified atherogenic lipoproteins induce expression of pentraxin-3 by human vascular smooth muscle cells | Q44985116 | ||
| Inflammation-induced endothelial dysfunction involves reduced nitric oxide bioavailability and increased oxidant stress | Q45056898 | ||
| Impaired endothelial function and elevated levels of pentraxin 3 in early-onset preeclampsia | Q45445071 | ||
| PTX3 as a potential endothelial dysfunction biomarker for severity of preeclampsia and IUGR. | Q45853741 | ||
| Expression of long pentraxin PTX3 in human adipose tissue and its relation with cardiovascular risk factors. | Q46525885 | ||
| Hyaluronan cross-linking: a protective mechanism in inflammation? | Q46743683 | ||
| Long pentraxin 3, a key component of innate immunity, is modulated by high-density lipoproteins in endothelial cells | Q46792302 | ||
| The long pentraxin PTX3 up-regulates tissue factor in activated monocytes: another link between inflammation and clotting activation | Q47265306 | ||
| Serum amyloid A (SAA) induces pentraxin 3 (PTX3) production in rheumatoid synoviocytes | Q47983765 | ||
| Pentraxin 3 in unstable angina and non-ST-segment elevation myocardial infarction | Q48395268 | ||
| Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials | Q48458509 | ||
| Regulation of leukocyte recruitment by the long pentraxin PTX3. | Q51774594 | ||
| Elevated plasma pentraxin 3 levels are associated with development and progression of diabetic retinopathy in Korean patients with type 2 diabetes mellitus. | Q53263086 | ||
| The long pentraxin PTX-3 in prevalent hemodialysis patients: associations with comorbidities and mortality. | Q53496784 | ||
| Expression of pentraxin 3 (PTX3) in human atherosclerotic lesions. | Q53502969 | ||
| Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure. | Q53510759 | ||
| Role of complement and Fc receptors in the protective activity of the long pentraxin PTX3 against Aspergillus fumigatus | Q56942510 | ||
| Deficiency of the Long Pentraxin PTX3 Promotes Vascular Inflammation and Atherosclerosis | Q56942567 | ||
| Cardioprotective Function of the Long Pentraxin PTX3 in Acute Myocardial Infarction | Q56942653 | ||
| Establishment of a High Sensitivity Plasma Assay for Human Pentraxin3 as a Marker for Unstable Angina Pectoris | Q56942761 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cardiovascular disease | Q389735 |
| P304 | page(s) | 25 | |
| P577 | publication date | 2016-01-01 | |
| P1433 | published in | Immunity and Ageing | Q15814340 |
| P1476 | title | The inflammatory protein Pentraxin 3 in cardiovascular disease | |
| P478 | volume | 13 |
| Q40061147 | A cross-sectional survey comparing a free treatment program for advanced schistosomiasis japonica to a general assistance program |
| Q49833796 | An exploratory factor analysis of inflammatory and coagulation markers associated with femoral artery atherosclerosis in the San Diego Population Study |
| Q47863451 | Anti-inflammatory and antiplatelet effects of non-vitamin K antagonist oral anticoagulants in acute phase of ischemic stroke patients. |
| Q51067081 | Association of genetic variants of pentraxin 3 rs3816527 with hypertension in Chronic kidney disease patients. |
| Q88779694 | Association of plasma pentraxin-3 levels with coronary risk factors and the lipid profile: a cross-sectional study in Japanese patients with stable angina pectoris |
| Q100516704 | Cardiovascular prognosis: a new role for ceramides and other cardiometabolites |
| Q89834282 | Combining Novel Biomarkers for Risk Stratification of Two-Year Cardiovascular Mortality in Patients with ST-Elevation Myocardial Infarction |
| Q97526121 | Elevated Levels of Pentraxin 3 Correlate With Neutrophilia and Coronary Artery Dilation During Acute Kawasaki Disease |
| Q101403078 | Expression of CARD8 in human atherosclerosis and its regulation of inflammatory proteins in human endothelial cells |
| Q92393610 | Inflammation, depression and cardiovascular disease in women: the role of the immune system across critical reproductive events |
| Q91970155 | Long Pentraxin 3 as a Broader Biomarker for Multiple Risk Factors in End-Stage Renal Disease: Association with All-Cause Mortality |
| Q91351180 | Omentin-regulated proteins combine a pro-inflammatory phenotype with an anti-inflammatory counterregulation in human adipocytes: A proteomics analysis |
| Q91874565 | Pentraxin-3 is a candidate biomarker on the spectrum of severity from pre-eclampsia to HELLP syndrome: GenPE study |
| Q90472914 | Periodontitis and vascular inflammatory biomarkers: an experimental in vivo study in rats |
| Q93139120 | Plasma PTX3, MCP1 and Ang2 are early biomarkers to evaluate the severity of sepsis and septic shock |
| Q60929441 | Protein array profiling of circulating angiogenesis-related factors during bevacizumab containing treatment in metastatic colorectal cancer |
| Q48293075 | Relationship Between Plasma Pentraxin 3 Concentration and Platelet Indices in Patients With Stable Coronary Artery Disease |
| Q46414850 | Synergistic Cardioprotective Effects of Combined Chromium Picolinate and Atorvastatin Treatment in Triton X-100-Induced Hyperlipidemia in Rats: Impact on Some Biochemical Markers |
| Q55402074 | The Role of Endothelial Progenitors in the Repair of Vascular Damage in Systemic Sclerosis. |
| Q55023381 | Usefulness of Plasma Pentraxin 3 Levels in Acute and Chronic Inflammatory Diseases. |
Search more.